Jump to navigation Jump to search
Nocardia asteroides (yellow colonies).
Nocardia asteroides (yellow colonies).
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Nocardiaceae
Genus: Nocardia
Trevisan 1889

Nocardiosis Microchapters


Patient Information


Historical Perspective


Differentiating Nocardiosis from other Diseases

Epidemiology and Demographics


Risk Factors

Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray



Other Diagnostic Studies


Medical Therapy


Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nocardia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Nocardia

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nocardia

CDC on Nocardia

Nocardia in the news

Blogs on Nocardia

Directions to Hospitals Treating Nocardiosis

Risk calculators and risk factors for Nocardia

This page is about microbiologic aspects of the organism(s).  For clinical aspects of the disease, see Nocardiosis.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Nocardia is a genus of Gram-positive, catalase-positive, rod-shaped bacteria; some species are pathogenic (nocardiosis).[1] Nocardia are found worldwide in soil that is rich with organic matter. Most Nocardia infections are acquired by inhalation of the bacteria or through traumatic introduction.

Culture and staining

Nocardia colonies have a variable appearance, but most species appear to have aerial hyphae when viewed with a dissecting microscope, particularly when they have been grown on nutritionally-limiting media. Nocardia grow slowly on non-selective culture media, and are strict aerobes with the ability to grow in a wide temperature range. Some species are partially acid fast due to the presence of intermediate-length mycolic acids in their cell wall.


The various species of Nocardia are pathogenic bacteria with low virulence; therefore clinically significant disease most frequently occurs as an opportunistic infection in those with a weak immune system, such as small children, the elderly, and the immunocompromised. Nocardial virulence factors are the enzymes catalase and superoxide dismutase (which inactive reactive oxygen species that would otherwise prove toxic to the bacteria), as well as a "cord factor" (which interferes with phagocytosis by macrophages by preventing the fusion of the phagosome with the lysosome).

Clinical disease

Nocardia asteroides is the species of Nocardia most frequently infecting humans, and most cases occur as an opportunistic infection in immunocompromised patents.

The most common form of human nocardial disease is a slowly progressive pneumonia, whose common symptoms include cough, dyspnoea (shortness of breath), and fever. It is not uncommon for this infection to spread to the pleura. Pre-existing pulmonary disease, especially pulmonary alveolar proteinosis, increases the risk of contracting a Nocardia pneumonia.

Nocardia may also cause a variety of cutaneous infections such as actinomycetoma (especially Nocardia brasiliensis), lymphocutaneous disease, cellulitis and subcutaneous abscesses.

About 33% of people with Nocardia infection, this will take the form of encephalitis and/or cerebral abscess formation.


Antibiotic therapy with a sulfonamide is the treatment of choice. The most common sulfonamide used is trimethoprim-sulfamethoxazole. People who take trimethoprim-sulfamethoxazole for other reasons, such as prevention of pneumocystis jiroveci infection in AIDS, have fewer nocardia infections. High-dose imipenem and amikacin have also been used in refractory cases. Antibiotic therapy may have to be continued for six months to a year. Proper wound care is also critical.


Despite that Nocardia has interesting and important features such as production of antibiotics and aromatic compound-degrading or converting enzymes, the genetic study of this organism has been hampered by the lack of genetic tools. However, practical NocardiaE. coli shuttle vectors have been developed recently.[2]


  1. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. pp. pp. 460&ndash, 2. ISBN 0838585299.
  2. Chiba K, Hoshino Y, Ishino K, Kogure T, Mikami Y, Uehara Y, Ishikawa J (2007). "Construction of a Pair of Practical Nocardia-Escherichia coli Shuttle Vectors". Jpn J Infect Dis. 60 (1): 45–7. PMID 17314425.

Further reading

  • Ishikawa J, Yamashita A, Mikami Y, Hoshino Y, Kurita H, Hotta K, Shiba T, Hattori M (2004). "The complete genomic sequence of Nocardia farcinica IFM 10152". Proc Natl Acad Sci U S A. 101 (41): 14925–30. PMID 15466710.
  • Arceneaux, Jean. "Corynebacterium and Related Genera." Lecture to 2nd Year Medical Students at University of Mississippi Medical Center. 10/04/05.
  • Greenwood, David, Richard C.B. Slack, and John F. Peutherer. Medical Microbiology: A Guide to Microbial Infections, 16th ed. (2002). ISBN 0-443-07077-6

External links

de:Nocardia nl:Nocardia uk:Nocardia

Template:WH Template:WikiDoc Sources